An international open-label study on safety and efficacy of 177Lu-satoreotide tetraxetan in somatostatin receptor positive neuroendocrine tumours (NETs): An interim analysis

Conference Proceedings

GP Nicolas, C Ansquer, NP Lenzo, H Gronbaek, A Haug, S Navalkissoor, J-M Beauregard, N Germann, S McEwan, D Wild, RJ Hicks

Annals of Oncology | ELSEVIER | Published : 2020

Ipsen.